MAPT and Alzheimer disease: Conversely, other studies report protective effects of sTREM2 in reducing neurodegeneration and symptom progression in AD,62, 63 and TREM2 loss‐of‐function mutations are linked to higher AD risk64 and enhanced Aβ‐associated tau seeding in AD mice.65, 66